Compare DKS Co., Ltd. with Similar Stocks
Dashboard
1
With a growth in Net Profit of 61%, the company declared Very Positive results in Jun 26
- The company has declared positive results for the last 11 consecutive quarters
- INTEREST COVERAGE RATIO(Q) Highest at 7,200
- ROCE(HY) Highest at 17.68%
- DEBT-EQUITY RATIO (HY) Lowest at 11.6 %
2
With ROCE of 15.27%, it has a attractive valuation with a 2.33 Enterprise value to Capital Employed
3
Consistent Returns over the last 3 years
Stock DNA
Specialty Chemicals
JPY 117,421 Million (Small Cap)
20.00
NA
0.00%
0.09
14.44%
2.26
Revenue and Profits:
Net Sales:
27,501 Million
(Quarterly Results - Jun 2026)
Net Profit:
3,733 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
56.87%
0%
56.87%
6 Months
28.22%
0%
28.22%
1 Year
151.61%
0%
151.61%
2 Years
409.06%
0%
409.06%
3 Years
742.74%
0%
742.74%
4 Years
501.54%
0%
501.54%
5 Years
323.53%
0%
323.53%
DKS Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.18%
EBIT Growth (5y)
14.90%
EBIT to Interest (avg)
17.86
Debt to EBITDA (avg)
2.35
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
1.01
Tax Ratio
26.20%
Dividend Payout Ratio
24.74%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
8.56%
ROE (avg)
7.07%
Valuation key factors
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
2.55
EV to EBIT
15.28
EV to EBITDA
11.17
EV to Capital Employed
2.33
EV to Sales
1.66
PEG Ratio
0.33
Dividend Yield
NA
ROCE (Latest)
15.27%
ROE (Latest)
12.87%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot : Dec 2011
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.03%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
27,501.00
22,677.00
21.27%
Operating Profit (PBDIT) excl Other Income
5,904.00
3,916.00
50.77%
Interest
82.00
66.00
24.24%
Exceptional Items
0.00
-286.00
100.00%
Consolidate Net Profit
3,733.00
2,334.00
59.94%
Operating Profit Margin (Excl OI)
186.10%
134.40%
5.17%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 21.27% vs 0.35% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is 59.94% vs -3.23% in Mar 2026
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
82,886.00
73,255.00
13.15%
Operating Profit (PBDIT) excl Other Income
13,329.00
8,575.00
55.44%
Interest
280.00
260.00
7.69%
Exceptional Items
-286.00
-365.00
21.64%
Consolidate Net Profit
7,299.00
3,820.00
91.07%
Operating Profit Margin (Excl OI)
122.00%
73.10%
4.89%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 13.15% vs 16.06% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 91.07% vs 132.64% in Mar 2025
About DKS Co., Ltd. 
DKS Co., Ltd.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available






